Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MORGAN STANLEY

(MS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Morgan Stanley : Good timing to anticipate a continuation of the trend

09/23/2021 | 02:52am EDT
long trade
Live
Entry price : 101.76$ | Target : 110.75$ | Stop-loss : 95.35$ | Potential : 8.83%
Morgan Stanley's shares display attractive technical aspects to anticipate a comeback of the underlying trend.
Investors have an opportunity to buy the stock and target the $ 110.75.
Morgan Stanley : Morgan Stanley : Good timing to anticipate a continuation of the trend
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses
  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • The company's enterprise value to sales, at 5.03 times its current sales, is high.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart
Subsector Other Investment Banking & Brokerage Services
1st jan.Capitalization (M$)Investor Rating
MORGAN STANLEY49.04%183 750
THE CHARLES SCHWAB CORPORAT..52.53%152 739
THE GOLDMAN SACHS GROUP, IN..53.98%130 703
CITIC SECURITIES COMPANY LI..-15.10%46 846
CSC FINANCIAL CO., LTD.-18.74%30 662
CHINA INTERNATIONAL CAPITAL..-11.33%28 351
CHINA MERCHANTS SECURITIES ..-25.19%22 177
HUATAI SECURITIES CO., LTD.-9.61%20 966
RAYMOND JAMES FINANCIAL, IN..53.84%20 622
SHENWAN HONGYUAN GROUP CO.,..-0.19%19 107
GUOSEN SECURITIES CO., LTD.-15.84%17 149
More Results

ę MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2021 59 651 M - -
Net income 2021 14 157 M - -
Net Debt 2021 112 B - -
P/E ratio 2021 13,1x
Yield 2021 2,06%
Capitalization 184 B 184 B -
EV / Sales 2021 4,96x
EV / Sales 2022 5,05x
Nbr of Employees 72 000
Free-Float 71,1%
Upcoming event on MORGAN STANLEY
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Last Close Price 102,14 $
Average target price 108,96 $
Spread / Average Target 6,67%
EPS Revisions
Managers and Directors
James Patrick Gorman Chairman & Chief Executive Officer
Andrew Michael Saperstein Co-President
Edward N. Pick Co-President
Sharon Yeshaya Chief Financial Officer
Robert P. Rooney Head-Technology, Operations & Firm Resilience